Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1966 1
1982 1
1989 1
1990 1
1993 1
1995 4
1996 1
1997 3
1998 1
1999 3
2000 6
2001 5
2002 4
2003 3
2004 2
2005 11
2006 3
2007 4
2008 4
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 10574497

57 results
Results by year
Filters applied: . Clear all
Page 1
Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys.
Moshfeghi D, Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K. Moshfeghi D, et al. Ophthalmic Surg Lasers. 1999 Nov-Dec;30(9):750-3. Ophthalmic Surg Lasers. 1999. PMID: 10574497
Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM. Mori K, et al. Ophthalmology. 1999 Jul;106(7):1384-91. doi: 10.1016/S0161-6420(99)00729-0. Ophthalmology. 1999. PMID: 10406627
Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
Peyman GA, Kazi AA, Moshfeghi D, Unal M, Khoobehi B, Yoneya S, Mori K, Rivera I. Peyman GA, et al. Ophthalmic Surg Lasers. 2000 Jul-Aug;31(4):323-7. Ophthalmic Surg Lasers. 2000. PMID: 10928670
Threshold power levels for NPe6 photodynamic therapy.
Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA. Kazi AA, et al. Ophthalmic Surg Lasers. 2000 Mar-Apr;31(2):136-42. Ophthalmic Surg Lasers. 2000. PMID: 10743925
Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
Kikuchi T, Asakura T, Aihara H, Shiraki M, Takagi S, Kinouchi Y, Aizawa K, Shimosegawa T. Kikuchi T, et al. Anticancer Res. 2003 Nov-Dec;23(6C):4897-900. Anticancer Res. 2003. PMID: 14981942
Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM. Mori K, et al. Retina. 2001;21(5):499-508. doi: 10.1097/00006982-200110000-00013. Retina. 2001. PMID: 11642380
Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL, Juarez M, Allen R, Volz W, Albertson T. Chan AL, et al. Photodermatol Photoimmunol Photomed. 2005 Apr;21(2):72-8. doi: 10.1111/j.1600-0781.2005.00138.x. Photodermatol Photoimmunol Photomed. 2005. PMID: 15752124 Clinical Trial.
[Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y. Mori K, et al. Nippon Ganka Gakkai Zasshi. 1997 Feb;101(2):134-40. Nippon Ganka Gakkai Zasshi. 1997. PMID: 9124093 Japanese.
Intraocular biodistribution of mono-L-aspartyl chlorin e6 in a primate choroidal neovascularization model.
Mori K, Kanai K, Peyman GA, Yoneya S. Mori K, et al. Ophthalmic Surg Lasers Imaging. 2007 Mar-Apr;38(2):142-7. doi: 10.3928/15428877-20070301-09. Ophthalmic Surg Lasers Imaging. 2007. PMID: 17396695
Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
Nagae T, Aizawa K, Uchimura N, Tani D, Abe M, Fujishima K, Wilson SE, Ishimaru S. Nagae T, et al. Lasers Surg Med. 2001;28(4):381-8. doi: 10.1002/lsm.1066. Lasers Surg Med. 2001. PMID: 11344521
57 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback